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Jorrit M. EnserinkAbstract
The ubiquitin family member Sumo has important functions in many cellular processes including DNA repair,
transcription and cell division. Numerous studies have shown that Sumo is essential for maintaining cell homeostasis
when the cell encounters endogenous or environmental stress, such as osmotic stress, hypoxia, heat shock, genotoxic
stress, and nutrient stress. Regulation of transcription is a key component of the Sumo stress response, and multiple
mechanisms have been described by which Sumo can regulate transcription. Although many individual substrates
have been described that are sumoylated during the Sumo stress response, an emerging concept is modification of
entire complexes or pathways by Sumo. This review focuses on the function and regulation of Sumo during the stress
response.
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Several small ubiquitin-like molecules were identified
during the 1990s, including Sumo (Small ubiquitin-like
modifier) [1]. Despite limited sequence similarity, Sumo
is structurally related to ubiquitin with a similar protein
fold. [2], although the distribution of charged residues
on the surface of the Sumo molecule differs from that of
ubiquitin [3]. The budding yeast Saccharomyces cerevi-
siae only expresses a single form of Sumo (encoded by
the SMT3 gene), whereas mammalian cells express four;
Sumo1, −2,-3,-4.
During recent years it has become clear that Sumo has
important functions in normal cell homeostasis, in large
part through regulation of transcription (reviewed in
Chymkowitch et al., submitted). However, Sumo is also
very important for the cellular stress response, and many
cellular stresses result in increased formation of Sumo
conjugates. Sumo can be covalently attached to a large
number of proteins to regulate their fate, localization
and function. The physiological significance of many of
these sumoylation events remains unknown, which is in
part due to the fact that Sumo can be attached to mul-
tiple components of an entire complex, and preventing
the attachment of Sumo to a single component of the
complex often has little or no clear effect. Furthermore,
when a given Sumo site is mutated, Sumo is sometimesCorrespondence: jorrit.enserink@rr-research.no
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ently little effect on the overall outcome. In contrast
to the ubiquitination machinery, the sumoylation ma-
chinery only consists of very few components, raising
the question how specificity is achieved and how the
activity of the Sumo pathway is regulated.
The scope of this review is to provide an overview of
the function of Sumo in the cellular stress response, in
particular transcription, and to highlight a number of
key questions that remain to be answered.Protein sumoylation
The sumoylation machinery
Similar to ubiquitination, sumoylation occurs through a
series of biochemical steps catalyzed by a set of well-
conserved enzymes (Fig. 1 and Table 1). In the first step,
Sumo, which is expressed as an inactive precursor pro-
tein, is processed by cysteine-specific Sumo proteases
(ULPs in yeast, SENPs in mammals) that remove a small
peptide from the C-terminus. This exposes a di-glycine
motif, which is subsequently linked to the E1 enzyme, a
dimer consisting of Sae1 and Sae2 (Aos1 and Uba2 in
S. cerevisiae). This step involves the covalent attachment
of Sumo to a reactive cysteine residue in Sae2 through
ATP-dependent thioesterification [4]. Through thioester
linkage, Sumo is then transferred to a cysteine residue of
the E2 conjugating enzyme Ubc9. In vitro, the E2 en-
zyme is sufficient for conjugating Sumo to a lysine resi-
due in the substrate, although it is believed that thise distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://








Fig. 1 Overview of the Sumo pathway
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stance, E3 ligases can serve as a scaffold that brings to-
gether Sumo-charged Ubc9 and the substrate, thereby
promoting efficiency and specificity of the sumoylation
process. Alternatively, E3 ligases can stimulate the E2
enzyme to transfer Sumo to its substrate.
An important aspect of protein sumoylation is that it
is a dynamic and reversible process. Sumoylated pro-
teins can be desumoylated by the same proteases that
convert the inactive Sumo precursor to its reactive
form (ULPs/SENPs). These enzymes have important
functions in spatial regulation of Sumo turnover [5],
which is crucial for many cellular processes including
chromosome cohesion, mitosis and transcription [6–8].
In S. cerevisiae, the activity of Ulp1 and Ulp2 towards
sumoylated proteins is in large part dependent upon
their localization; Ulp1 activity in particular appears to
be highly localized at nuclear pore complexes, whereas
Ulp2 may be more active towards proteins located in
the nucleoplasm [9, 10]. However, how the enzymaticTable 1 The sumoylation machinery in S. cerevisiae and mammals
Protein function S. cerevisiae H. sapiens
Sumo Smt3 SUMO-1,-2,-3
E1 activating enzyme Aos1•Uba2 Sae1•Sae2
E2 conjugating enzyme Ubc9 UBC9
E3 ligase Siz1, Siz2, Cst9,
Mms21
PIAS1,-2,-3,-4; MZIZ1; NSE2;
RanBP2; Pc2; MUL1; TOPORS;
HDAC4,-7; TRAF7; FUS; RSUME
Sumo protease Ulp1, Ulp2 SENP1,-2,-3,-4,-5,-6,-7; DESI1,-2;
USPL1activity of Sumo proteases is regulated is currently not
well understood (also see below).
Consensus motifs for sumoylation
Sumoylation of substrates preferentially occurs on a ly-
sine residue in the canonical Sumo consensus motif
ΨKx(D/E), in which Ψ is a large hydrophobic residue
and x is any amino acid followed by an acidic residue
[11]. The hydrophobic and acidic residues promote sta-
bility of the interaction between the substrate and the E2
enzyme [12–14]. Several variations on this sumoylation
motif have been identified, including so-called negatively
charged amino acid-dependent Sumo motifs (NDSMs)
and phosphorylation-dependent Sumo motifs (PDSMs).
PDSMs are basically extended versions of the canonical
Sumo motif (ψKx(D/E)xxSP), and phosphorylation of
this motif by proline-directed kinases generally increases
sumoylation efficiency [15]. Phosphorylated PDSMs and
NDSMs likely promote sumoylation efficiency by in-
creasing the stability of the interaction between Ubc9
and the substrate, because the negatively charged phos-
phate (in case of PDSM) or the negatively charged
amino acids (NDSM) interact with basic residues on the
surface of Ubc9 [15, 16]. It is important to note that
sumoylation can also occur on lysines that do not con-
form to known Sumo consensus motifs [17–19], such as
the well-studied K164 Sumo site in PCNA [20], and data
from high-throughput studies indicate that non-consensus
sumoylation may be a relatively common event [19, 21].
How these sites are recognized by the sumoylation ma-
chinery remains to be determined.
Sumo chains
While conjugated Sumo is probably best studied in its a
monomeric form, Sumo can also form oligomeric chain
structures. In S. cerevisiae, these are primarily formed
through K15 linkage (K11 in mammalian Sumo-2/3),
which is part of the canonical Sumo consensus motif,
and requires the E1 enzyme and Ubc9 [22, 23]. Sumo
chains are best characterized in their role as an indirect
protein degradation signal; they can recruit conserved
E3 ubiquitin ligases known as Sumo targeted ubiquitin
ligases (STUbLs), which subsequently ubiquitinate the
polysumoylated protein to target it for proteasomal deg-
radation [24]. Some examples of STUbL targets are
PML, c-Myc, the viral Tax protein, the Drosophila
transcriptional repressor Hairy, the S. cerevisiae basal
transcription factor Mot1, and the A. thaliana tran-
scriptional repressor CDF2 [25–29]. Apart from its
function in protein degradation, the physiological signifi-
cance of Sumo chains remains poorly understood. A glo-
bal study of Sumo chain function in S. cerevisiae
indicates that Sumo chains are involved in regulation of
transcription and ordering of chromatin structure [30],
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acterized in detail.
Sumo interaction motifs
Sumoylation of proteins adds a bulky moiety that can
affect the interaction with other proteins. For instance,
sumoylation of PCNA on K127 prevents the interaction
between PCNA and the chromatin cohesion protein
Eco1 [31]. In another example, the covalent conjugation
of SUMO-1 to lysine 341 of the base excision repair en-
zyme thymine DNA glycosylase (TDG) blocks the inter-
action with the histone acetyltransferase CBP/p300 [32].
However, most studies have focused on the function of
Sumo in promoting protein-protein interactions. Here,
Sumo can provide an interaction surface for specific
binding partners, which typically interact with Sumo
through a Sumo interaction motif (SIM). The first re-
ported SIM was identified through a two-hybrid screen
that used the p53 family member p73α as bait [33]. It
was found that p73α became sumoylated in yeast, and
this sumoylated form of p73α subsequently interacted
with various mammalian interaction partners. By compar-
ing common motifs in these interaction partners, it was
found that they share a common ΦΦxSxS[D/E][D/E][D/E],
where Φ is a hydrophobic amino acid [33]. Because this
motif is centered on the two serines it became known
as the ‘SxS’ motif. However, it was later found that
these two serines are not critical for Sumo binding, and
that the two hydrophobic amino acids play a much
more important role; in fact, NMR spectroscopic
characterization of the interaction between mammalian
SUMO-1 and peptides derived from known Sumo bind-
ing proteins identified a hydrophobic core with the
consensus [V/I]x[V/I][V/I] [34]. Subsequent studies
confirmed the importance of this hydrophobic core,
and structural studies have shown that in complex with
Sumo the hydrophobic side chains of the SIM interact
with a hydrophobic pocket on the SUMO surface [35, 36].
This canonical SIM is often flanked by acidic amino acids
[37, 38], not unlike the originally reported SxS motif [33].
In some cases, phosphorylated serine residues fulfill the
function of these acidic amino acids. These phospho-SIMs
have been identified in PML, EXO9 and in the PIAS pro-
teins, which are phosphorylated by the constitutively ac-
tive casein kinase 2 (CK2) [39]. The phosphorylated
residues in the SIM interact with a lysine residue on the
Sumo surface to stabilize the SIM-Sumo interaction [39].
In addition to providing the cell with a mechanism for
temporal and spatial control of protein sumoylation,
phospho-SIMs may add specificity to selection of appro-
priate Sumo substrates.
Interestingly, the Sumo pathway often targets multiple
components of protein complexes and pathways [40–42].
This phenomenon of protein group sumoylation was firstdescribed for yeast septins and was more recently also ob-
served in the DNA checkpoint/repair pathways. The exact
physiological significance of protein group sumoylation is
presently not clear, although it has been proposed that
multiple Sumo-SIM interactions serve as a ‘Sumo glue’ to
stabilize the integrity of the complex [42]. Perhaps protein
group sumoylation, in which multiple relatively weak
Sumo-SIM interactions cooperate to provide increased
complex stability, is important for buffering the system.
More specifically, it is likely that significant Sumo noise
exists in the cell, because sumoylation is a common event
(up to 10% of all mammalian proteins may be Sumo tar-
gets [43]); potential SIMs are ubiquitous (4892 instances
of the [V/I]x[V/I][V/I] motif can be found in the S. cerevi-
siae proteome, totaling 2919 proteins); and under normal
growth conditions a large pool of free Sumo exists in the
cell, which could compete with sumoylated proteins for
binding to SIMs. To overcome this noise, protein group
sumoylation may be a strategy of the cell to increase the
signal-to-noise ratio of Sumo-SIM interactions to generate
a consistent output.
The Sumo stress response
Early studies with mammalian and yeast cells found that
Sumo is important for the cellular response to stress,
such as heat shock, DNA damage, oxidative stress and
ethanol stress [44, 45]. Although Sumo is crucial for the
stress response in plants, here I will mainly focus on
studies conducted in yeast and vertebrates, referring the
reader to recent reviews on Sumo in the plant stress
response [46–48].
DNA damage response
Sumo has been studied extensively in the context of
DNA damage, and except for a few specific examples I
will not discuss this in great detail here and instead refer
the reader to recent reviews [49, 50]. One of the best
known targets of Sumo in the DNA damage response is
PCNA[20]. PCNA is a trimeric complex that functions
as a sliding clamp and processivity factor for DNA poly-
merases. In response to endogenous and exogenous
DNA damage PCNA can be modified by ubiquitin and
Sumo [20, 51] (Fig. 2). Sumoylation occurs preferentially
on the evolutionarily conserved K164, and to a lesser ex-
tent on the yeast-specific residue K127 [20]. Sumoylated
PCNA recruits the helicase Srs2, which has a SIM in its
extreme C-terminus. Srs2 is an inhibitor of homologous
recombination (HR) [52, 50, 53], and recruitment of
Srs2 is believed to suppress undesirable recombination
events during chromosome replication [54]. Srs2 itself is
also a target of Sumo [55], and sumoylation of Srs2 appears
to interfere with binding of Srs2 to sumoylated PCNA [56],
although the exact physiological consequences for the
DNA replication and repair process remain unclear.
Inhibition of recombination
K127/164 K164 K164

















Fig. 2 Regulation of PCNA by ubiquitin and Sumo. When cells are treated with high doses of MMS, PCNA becomes Sumo-modified primarily on
K164 and to a lesser extent K127, resulting in recruitment of HR inhibitor Srs2. At lower levels of DNA damage PCNA is ubiquitinated mainly on
K164 (and to a lesser degree also on other sites [113, 51]). This promotes lesion bypass in case of monoubiquitination, whereas polyubiquitinated PCNA
induces template switching and error-free DNA repair
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age response proteins are sumoylated in response to
DNA damage [50, 57]. A recurrent theme appears to be
protein group sumoylation [40, 42]. For instance, expos-
ure of single stranded DNA (ssDNA) induces sumoyla-
tion of several proteins involved in HR, which is thought
to promote DNA double strand break repair. For at least
some of these proteins, simply localizing to the chroma-
tin compartment is sufficient for sumoylation to occur,
probably because it results in their colocalization with
the chromatin-bound E3 ligase Siz2. Why Siz2 specifically
sumoylates HR proteins and not any other chromatin-
bound protein remains to be understood.
Viral infections
Infections with pathogens like viruses trigger a major
stress response. Interferon (IFN) plays a central role in
the response to viral infections. At the cellular level, IFN
has a number of effects, most notably an increase in the
number and size of so-called promyelocytic leukemia
protein-nuclear bodies (PML-NBs). PML-NBs are dy-
namic nuclear substructures that consist of a very large
number of proteins centered around the PML protein,
which is essential for organizing these proteins into
PML-NBs [58, 59]. Although the PML protein has been
extensively studied in the context of acute promyelocytic
leukemia, in which it is fused to the retinoic acid recep-
tor to drive cancer cell proliferation and survival, in
healthy cells it fulfills many functions essential for nor-
mal cell homeostasis. For instance, PML-NBs have been
implicated in transcription, mRNA transport, the DNA
damage response, telomere maintenance, the cellularstress response, apoptosis, stem cell maintenance and
senescence [60, 61, 59]. PML-NBs also serve an import-
ant function in the antiviral response [60]. For instance,
PML−/− mice exhibit increased viral load after infection
with lymphocytic choriomeningitis virus (LCMV) and
vesicular stomatitis virus (VSV) [62]. One way PML-NBs
inhibit VSV infections is by recruiting and activating p53
to induce apoptosis, thereby killing the infected cell to
protect the organism [60].
Sumo is a key regulator of PML function [59]. PML
directly binds Ubc9, resulting in sumoylation on at least
three lysines, K65, K160 and K490. Interestingly, PML
has Sumo E3 ligase activity [63], which may mediate
sumoylation of many components of PML-NBs [59]. It
is believed that protein group sumoylation of these fac-
tors promotes the assembly of PML-NBs through mul-
tiple Sumo-SIM interactions [59] (Fig. 3a). Indeed,
sumoylation of PML is essential for formation of PML-
NBs, and a non-sumoylatable PML mutant fails to recruit
key components of PML-NBs, including the transcriptional
regulators SP100 and DAXX [59].
The importance of Sumo in the antiviral stress re-
sponse is highlighted by the fact that sumoylation of
PML increases upon infection with poliovirus, leading to
recruitment of p53 and induction of apoptosis [64].
Not surprisingly, viruses have developed several mech-
anisms that disrupt PML-NBs, some of which target
the sumoylation machinery. For instance, the chicken
embryo lethal orphan (CELO) virus, which is an avian
adenovirus, expresses a protein called Gam-1. Gam-1
blocks the sumoylation pathway by inhibiting forma-
























Fig. 3 Viruses can target the Sumo pathway to disrupt PML-NBs. a, Several components of PML-NBs are targets of Sumo, and multiple
Sumo-SIM interactions may promote complex stability. b, The HSV viral protein ICP0 can function as a STUBL to degrade sumoylated PML,
thereby disrupting structural integrity of PML-NBs
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teins [65, 66].
Two other examples of viral proteins that target the
Sumo pathway to disperse PML-NBs are the herpes sim-
plex virus ICP0 protein and the human cytomegalovirus
IE1 protein. Both these proteins interfere with sumoyla-
tion of PML, resulting in disassembly of PML-NBs [67].
ICP0 is believed to function as a STUbL that specifically
binds Sumo-modified proteins including PML, resulting
in their ubiquitination to target them for proteasomal
degradation (Fig. 3b). Many other viruses have devel-
oped mechanisms that thwart the PML-NB antiviral
defense system [68, 69]. Taken together, these studies
show that Sumo plays an important role in the cellular
antiviral stress response.
Endoplasmic reticulum (ER) stress response
Anomalies in ER function can result in the accumulation
of misfolded proteins, which is often referred to as ER
stress. ER stress results in activation of the unfolded pro-
tein response (UPR), which aims to re-establish cellular
homeostasis by reducing the amount of unfolded pro-
teins. Notably, while the UPR promotes cell viability at
low doses of ER stress, it can also induce apoptosis when
ER stress is not mitigated.
As illustrated in Figure 4, the UPR consists of three
branches, i.e. inositol-requiring protein 1 (IRE1), protein
kinase RNA-like ER kinase (PERK) and activatingtranscription factor 6 (ATF6) [70]. IRE1 contains both a
kinase and an endoribonuclease domain. ER stress in-
duces dimerization and autophosphorylation of IRE1,
leading to activation of the cytosolic RNase domain. The
RNase domain subsequently excises a small intron from
the mRNA encoding the transcription factor X box-
binding protein 1 (XBP1). This alters the reading frame
of the mRNA, resulting in translation of the active tran-
scription factor, known as ‘spliced XBP1’ (XBP1s). XBP1s
then activates its target genes, which have important
functions in the ER-associated protein degradation
(ERAD) pathway, ER protein import, protein folding,
and lipid synthesis [70].
Interestingly, the Sumo pathway has multiple effects
on the UPR. For instance, in mammalian cells XBP1s is
sumoylated by PIAS2 on two lysines in the C-terminal
transactivation domain, which inhibits the transcrip-
tional activity of XBP1s [71]. Upon ER stress, the Sumo
protease SENP1 desumoylates XBP1s to promote its
transcriptional activity [72]. This effect of Sumo on
XBP1 appears to be conserved in C. elegans [73]. Fur-
thermore, mRNA encoding Sumo is degraded upon ER
stress in Drosophila [74], and although the physiological
consequences remain unknown, it is tempting to specu-
late that depletion of Sumo further boosts the activity of
XBP1s. Finally, binding of mammalian Ubc9 to the leu-
cine zipper motif of XBP1s increases XBP1s stability to













Fig. 4 Sumo and the ER stress response. Unfolded proteins trigger the ER stress response, inducing processing of XBP mRNA by Ire1, ultimately
yielding active XBP1s. Sumoylation of XBP1s and the physical interaction with Ubc9 inhibit its transcriptional activity
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[75]. Together, these findings show that the Ubc9-Sumo
pathway has a negative effect on the ER stress response.
Regulation of transcription by Sumo
We have recently reviewed the diverse functions of
Sumo in transcriptional regulation during normal
growth conditions (Chymkowitch et al., submitted),
and here I will mainly focus on regulation of tran-
scription during cell stress.
Sumo is best known for its inhibitory function in tran-
scription [76]. Several mechanisms have been described
by which Sumo can inhibit transcription (Fig. 5). For in-
stance, as has been described for the transcription factor
Atf7 [77], Sumo can inhibit nuclear entry of transcrip-
tion factors (Fig. 5a); it can prevent recruitment of
general transcription factors (Fig. 5b); or it can block
binding of transcription factors to specific sequences in
the promoter (Fig. 5c). The sumoylation machinery can
also inhibit transcription by competing for lysines that
are targets for other modifications associated with tran-
scriptional activation, such as acetylation, methylation or
ubiquitination (Fig. 5d). This has been reported for
STAT5A, where inhibitory sumoylation competes with an
activating acetyl modification of K696 [78]. In a relatedmechanism, Sumo can prevent ubiquitin-mediated deg-
radation of transcriptional inhibitors (Fig. 5e), as was
described for IκBα [79]. IκBα is an inhibitor of the
transcription factor NFκB, and IκBα can be ubiquinated
on K21, which results in its proteasomal degradation.
This relieves inhibition of NFκB, which subsequently
activates transcription. However, K21 of IκBα is also a
target for sumoylation, and Sumo-modified IκBα pre-
vents ubiquitin-mediated degradation of IκBα, thereby
preventing activation of NFκB [79]. Sumoylation of
transcription factors can also result in recruitment of
transcriptional repressors (Fig. 5f ). An example of this
mechanism is sumoylation of the transcription factor
Elk-1, which results in recruitment of HDAC-2, which
silences chromatin by deacetylating histones [80]. Tran-
scriptional repressors can themselves be activated by
sumoylation to create a repressive chromatin environ-
ment (Fig. 5g); for example, sumoylation of HDAC1
promotes transcriptional repression in vivo [81].
Sumo-mediated inhibition of transcription is likely to
be an important aspect of the cellular stress response.
For instance, various stresses including heat shock, etha-
nol treatment and osmotic stress induce PIAS-mediated
sumoylation of c-Myb, which results in inhibition of its
transcriptional activity [82]. Since c-Myb is a major
Sumo competes with activating modifications
Sumoylation prevents nuclear entry
Sumo inhibits promoter binding
TF -K- SumoTF -K-TF





































Fig. 5 Multiple mechanisms of transcriptional regulation by Sumo. a, Sumoylation prevents nuclear entry. b, Sumo prevents recruitment of
general transcription factors (GTFs). c, Sumo inhibits promoter binding of the transcription factor. d, Sumo competes with other modifications
that activate transcription. e, Sumo prevents degradation of an inhibitor of a transcription factor. f, Sumo recruits a transcriptional repressor that
silences the local chromatin environment. g, Sumoylation increases the activity of a transcriptional repressor to inhibit transcription
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may induce sumoylation of c-Myb to switch off the tran-
scriptional programs required for cell proliferation.
Sumo can also activate transcription during cell stress.
For instance, sumoylation of the heat shock transcription
factors HSF1 and HSF2 increases their DNA binding
activity, resulting in increased expression of heat shock
proteins which provide protection against protein-
damaging stress [83, 84]. Another example is the activa-
tion of NFκB in response to genotoxic stress. Genotoxic
stress induces sumoylation and nuclear localization of
NEMO, an activator of the IκB kinase IKK. This
NEMO-induced IKK activation leads to phosphorylation
of the NFκB inhibitor IκB, resulting in proteasomal deg-
radation of IκB and activation of NFκB to transcribe
pro-survival genes [85, 86].Together, these studies illustrate the complexity of
Sumo’s function in regulating transcription during the
cellular stress response, and it is largely unclear how
specificity is achieved in this process (also see below).
Sumo and the nutrient response
One major source of stress is a limitation in nutrient
availability. Maintaining cellular homeostasis in the face
of changes in nutrient supply is essential for the growth
and development of all organisms, from unicellular mi-
croorganisms to higher eukaryotes. Cellular mechanisms
have evolved that sense environmental alterations and
evoke responses that act to preserve homeostasis. When
a cell detects a reduction in its nutrient supply, it
activates signal transduction pathways that elicit inte-
grated responses that alter cell metabolism by reducing
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utilization of alternative nutrient sources. One key elem-
ent of the response to nutrient starvation is rewiring of
gene expression programs. Target of rapamycin complex
1 (TORC1), a large protein complex that contains the
Tor kinase, play a central role in the cellular response to
nutrient status [87–89]. TORC1 activity strongly depends
on nutrient availability, in particular nitrogen. Under
nitrogen-rich conditions, TORC1 promotes growth and
proliferation-related processes, like protein synthesis,
ribosome biogenesis, and tRNA synthesis, while inhibit-
ing catabolic processes, like autophagy [87–89]. Con-
versely, inhibition of TORC1 activity by nutrient
depletion (or addition of the TORC1-specific inhibitor
rapamycin) results in a metabolic switch from anabolism
to catabolism [87–89]. This involves many cellular pro-
cesses, including rewiring of transcriptional programs
[87, 90]. An important set of genes whose expression de-
pends upon TORC1 includes genes involved in regula-
tion of translation, such as the RNAPII-transcribed
ribosomal protein genes (RPGs) and the RNAPIII-
transcribed tRNA genes. In S. cerevisiae, TORC1 activates
RPG transcription by promoting phosphorylation of the
transcription factors Sfp1 and Ifh1, leading to their
recruitment to PRG promoters where they activate tran-
scription together with several other transcription factors,
including Rap1 and Fhl1 (Fig. 6a) [91–94]. In addition,
TORC1 regulates transcription of RNAPIII-dependent
genes by phosphorylating the transcriptional repressor
Maf1, which results in nuclear exclusion of Maf1 (Fig. 6a)
[88]. Nutrient stress results in inactivation of TORC1, lead-
ing to dephosphorylation of Sfp1, Ifh1 and Maf1. Subse-
quently, dephosphorylated Sfp1 and Ifh1 leave RPG
promoters, resulting in loss of RPG transcription, whereas
dephosphorylation of Maf1 causes it to enter the nucleus
where it binds and inhibits RNAPIII to block transcription
of tRNA genes (Fig. 6b) [88, 89]. This ultimately results in
downregulation of the translational capacity of the cell
until nutrient conditions improve [89].
We recently found that nutrient stress profoundly af-
fects cellular sumoylation patterns in yeast [95]. Nutrient
stress particularly inhibits sumoylation of several tran-
scription factors, especially components of the RNAPIII
polymerase. Preventing sumoylation of RNAPIII results
in strongly reduced tRNA expression levels [95]. Al-
though the molecular mechanism remains to be solved,
these findings indicate that sumoylation of RNAPIII is
required for its activity, and that nutrient stress inhibits
tRNA transcription by preventing sumoylation of
RNAPIII [95]. This may be conserved in human cells,
because several RNAPIII components have been identified
as Sumo targets in high-throughput proteomic studies, al-
though the functional consequences of these modifications
have not been studied [96–99].Interestingly, in human cells Sumo is also associated
with inhibition of RNAPIII-dependent transcription upon
nutrient stress. Specifically, downregulation of RNAPIII
during nutrient starvation requires sumoylation of Maf1,
and cells expressing a non-sumoylatable mutant of Maf1
do not fully repress tRNA transcription during starva-
tion [100]. These studies indicate that Sumo may dif-
ferentially regulate RNAPIII activity, although more
studies are required to fully understand how Sumo
regulates RNAPIII.
Another yeast transcription factor that is regulated by
Sumo is Rap1 [95, 101]. Rap1 becomes sumoylated on
multiple sites, and Sumo increases the transcriptional
activity of Rap1 at RPGs by promoting the recruitment
of TFIID [95]. Although the exact molecular mechanism
of TFIID recruitment to sumoylated Rap1 remains to be
revealed, most components of the TFIID complex con-
tain one or several SIMs, indicating that Sumo-SIM
interactions may be important.
Paradoxically, whereas nutrient stress results in de-
creased RPG transcription, Rap1 sumoylation is in-
creased under these conditions [95]. This is potentially
the result of a homeostatic feedback loop, where the cell
senses a decrease in its translational capacity and re-
sponds by attempting to restore RPG transcription by
sumoylating Rap1. Indeed, Rap1 sumoylation is essential
for maintaining a basal rate of RPG transcription under
nutrient stress, and preventing Rap1 sumoylation during
nutrient stress completely abolishes RPG transcription,
causing a strong decrease in cell viability [95].
Regulation of RPGs by Sumo is conserved in mamma-
lian cells, although the critical target is not the human
homolog of Rap1 but rather the transcription factor
scaffold attachment factor b1 (SAFB1). Together, these
studies show that Sumo plays an important role in pro-
moting cell growth and proliferation and that it is
strongly affected by the cell’s nutrient status.
How is the Sumo pathway activated by stress, and how is
specificity achieved?
It is still not very clear how specificity is achieved in the
Sumo pathway. A very large number of proteins can be
sumoylated, and an even larger number of proteins con-
tains potential SIMs. Yet, specific stresses induce sumoy-
lation of specific sets of proteins, and these sets of
proteins may be different between various organisms.
For instance, in yeast, DNA damage mainly induces
sumoylation of DNA damage response proteins, such as
proteins involved in HR [42], whereas in human cells
the Sumo network primarily consists of chromatin mod-
ifiers and transcription factors [102].
In yeast, specificity towards HR proteins has been sug-
gested to involve colocalization of Siz2 and HR proteins






























High RPG transcription High tDNA transcription
Low RPG transcription Low tDNA transcription
High nutrient levels, TORC1 active
Low nutrient levels, TORC1 inactive
Higher eukaryotes only?
Fig. 6 Regulation of pro-growth genes by Sumo. a, in the presence of sufficient nutrients, TORC1 and Ubc9 in transcription of pro-growth genes like
RPGs and tRNA genes. TORC1 increases phosphorylation of Sfp1 and Ifh1, leading to their recruitment to PRG promoters. Ubc9 sumoylates Rap1, which
enhances recruitment of TFIID to RPGs. Ubc9 also sumoylates RNAPIII components, which most likely is required for efficient tRNA transcription. TORC1
increases phosphorylation of Maf1, resulting in its nuclear exclusion. b, During nutrient stress TORC1 is inactive, leading to dephosphorylation of Sfp1
and Ifh1, which are then released from RPG promoters. Maf1 also becomes dephosphorylated, resulting in its nuclear entry where it binds
and inhibits RNAPIII. At least in mammals Maf1 is also sumoylated, which contributes to its repressive effect on RNAPIII. Whether this also
occurs in yeast is unknown
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Exactly how Ubc9 and Siz2 are regulated in this context
remains unclear. It is possible that phosphorylation helps
coordinate the Sumo pathway. In yeast, DNA damagecheckpoint kinases, such as Tel1 (yeast ATM), Mec1
(yeast ATR), Chk1 and Rad53 (yeast Chk2) phosphoryl-
ate many proteins involved in the DNA damage re-
sponse, including HR proteins [103]. Some of these
Enserink Cell Division  (2015) 10:4 Page 10 of 13phosphorylations may occur in PDSMs to promote sub-
sequent sumoylation. Phosphorylation-mediated coord-
ination of protein sumoylation could be a more general
model for the Sumo stress response, since cellular stress
activates several stress-induced kinases, such as p38 and
JNK in mammals and Slt2 and Hog1 in yeast.
Locally, the activity of components of the sumoylation
machinery may be regulated by post-translational modi-
fications. In yeast, the E1 enzymes Uba2 and Aos1 have
been found to be phosphorylated, although the func-
tional consequences have not been explored [104–106].
The E2 conjugase Ubc9 can be activated by phosphor-
ylation. In mammalian cells, Akt phosphorylates Ubc9
on T35, which promotes thioester bond formation be-
tween Ubc9 and Sumo to increase Ubc9 activity [107].
This also promotes sumoylation of Ubc9 itself, which is
believed to be important for substrate selection [108]. In
addition to Ubc9, Akt can also phosphorylate Sumo-1
(on T76), which promotes the stability of Sumo-1. Thus,
phosphorylation both activates Ubc9-Sumo and in-
creases specificity of the sumoylation pathway. Cdk1 can
also activate Ubc9 [109], although it phosphorylates
Ubc9 on a different residues than Akt, i.e. S71, which
falls within a full cyclin B-Cdk1 consensus site [110]. In
contrast to phosphorylation by Akt, Cdk1-dependent
phosphorylation does not result in increased autosumoyla-
tion of Ubc9 [109]. For both Akt- and Cdk1-dependent
phosphorylation, the exact molecular mechanism by
which phosphorylation activates Ubc9 remains to be
revealed.
Other components of the sumoylation machinery are
also kinase targets. For instance, the E3 ligase PIAS1 is
phosphorylated by IKK on S90, which results in its
localization to NF-κB-bound promoters where it inhibits
transcription [111]. Furthermore, in yeast the desumoy-
lating enzymes Ulp1 and Ulp2 have been found to be
extensively phosphorylated, although the physiological
relevance is unknown [106, 104, 103].
Finally, it worth mentioning that it was recently re-
ported that in yeast the Sumo stress response critically
depends upon active transcription, but does not require
translation [112]. The authors observed that the osmotic
shock-induced Sumo stress response does not appear to
be directly linked to the stress itself, but rather repre-
sents a synchronized wave of sumoylation that occurs as
a consequence of large-scale, coordinated changes in the
transcriptional program in response to environmental
stress [112]. This is an interesting observation, but it is
presently difficult to understand how such transcrip-
tional changes would result in sumoylation of specific
protein complexes; for instance, why do osmotic shock-
induced transcriptional changes not result in sumoyla-
tion of HR proteins, or other Sumo targets like septins
[41]? More detailed follow-up studies are required tounderstand how active transcription is linked to protein
group sumoylation.
Conclusions
Together, these studies show that Sumo plays an import-
ant role in maintaining cell homeostasis. Under optimal
conditions, Sumo promotes cell growth and proliferation
by activating pro-growth genes, whereas during cell
stress Sumo contributes to activation of pro-survival
pathways. Nonetheless, a lot remains to be learned about
the Sumo stress response and regulation of the sumoy-
lation machinery by phosphorylation and other post-
translational modifications. Another major question that
remains to be answered is how specificity is achieved.
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